Charlotte J Van Edom, Mario Gramegna, Luca Baldetti, Alessandro Beneduce, Thomas Castelein, Dieter Dauwe, Pascal Frederiks, Gennaro Giustino, Marc Jacquemin, Stefan P Janssens, Vasileios F Panoulas, Janine Pöss, Alexander Rosenberg, Hannah A I Schaubroeck, Benedikt Schrage, Guido Tavazzi, Thomas Vanassche, Leen Vercaemst, Dirk Vlasselaers, Pascal Vranckx, Jan Belohlavek, Diana A Gorog, Kurt Huber, Alexandre Mebazaa, Bart Meyns, Federico Pappalardo, Anna M Scandroglio, Gregg W Stone, Dirk Westermann, Alaide Chieffo, Susanna Price, Christophe Vandenbriele
Percutaneous ventricular assist devices (pVADs) are increasingly being used because of improved experience and availability. The Impella (Abiomed), a percutaneous microaxial, continuous-flow, short-term ventricular assist device, requires meticulous postimplantation management to avoid the 2 most frequent complications, namely, bleeding and hemolysis. A standardized approach to the prevention, detection, and treatment of these complications is mandatory to improve outcomes. The risk for hemolysis is mostly influenced by pump instability, resulting from patient- or device-related factors...
July 24, 2023: JACC. Cardiovascular Interventions